Efficacy of a Maintenance Treatment With TALAzoparib Following First Line Platinum-based Chemotherapy in Malignant MESOthelioma
Condition(s):Advanced Malignant Pleural or Peritoneal MesotheliomaLast Updated:July 9, 2020Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Advanced Malignant Pleural or Peritoneal MesotheliomaLast Updated:July 9, 2020Not yet recruiting
Condition(s):Mesothelioma; Pleural Mesothelioma; Wilms TumorLast Updated:August 2, 2023Active, not recruiting
Condition(s):MesotheliomaLast Updated:March 23, 2015Unknown status
Condition(s):Familial Cancer; BRCA1-Associated Protein-1 (BAP1) Mutations; Tumor Predisposition Syndrome (TPDS); MesotheliomaLast Updated:February 20, 2024Recruiting
Condition(s):Malignant Pleural MesotheliomaLast Updated:February 4, 2022Completed
Condition(s):Malignant Pleural MesotheliomaLast Updated:June 9, 2017Completed
Condition(s):MesotheliomaLast Updated:March 12, 2024Recruiting
Condition(s):Mesotheliomas PleuralLast Updated:January 17, 2023Recruiting
Condition(s):Mesothelioma, MalignantLast Updated:April 12, 2022Recruiting
Condition(s):Mesothelioma, MalignantLast Updated:June 13, 2019Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.